SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/549935DF9388C10242645CC3B573145FBADD84F03BDAE77B17EBB6B54FDB07526E1B12A427D79EDE40F1E32DF24586FD>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/549935DF9388C10242645CC3B573145FBADD84F03BDAE77B17EBB6B54FDB07526E1B12A427D79EDE40F1E32DF24586FD
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/549935DF9388C10242645CC3B573145FBADD84F03BDAE77B17EBB6B54FDB07526E1B12A427D79EDE40F1E32DF24586FD
http://www.w3.org/2000/01/rdf-schema#comment
"Fgfr2+/Y394C mice with a p38 kinase inhibitor attenuated skin abnormalities by reversing cell proliferation and differentiation to near normal levels."
xsd:string
http://purl.uniprot.org/uniprot/#_55E5E223EF337CEB6E36BCA6262701B99121FB18674328B235664A636852D90659E430225108D1066B356122C8A35553
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/549935DF9388C10242645CC3B573145FBADD84F03BDAE77B17EBB6B54FDB07526E1B12A427D79EDE40F1E32DF24586FD
http://purl.uniprot.org/uniprot/A1YYN0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/549935DF9388C10242645CC3B573145FBADD84F03BDAE77B17EBB6B54FDB07526E1B12A427D79EDE40F1E32DF24586FD
http://purl.uniprot.org/uniprot/#_A1YYN0-mappedCitation-22585574
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/549935DF9388C10242645CC3B573145FBADD84F03BDAE77B17EBB6B54FDB07526E1B12A427D79EDE40F1E32DF24586FD